Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Lineage Commitment01:21

Lineage Commitment

3.0K
Commitment is the  process whereby stem cells:
3.0K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Hematopoiesis01:21

Hematopoiesis

5.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.3K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temporal mapping of epithelial vs. immune cell inflammatory shifts in the neonatal intestinal mucosa.

Pediatric research·2025
Same author

Author Correction: PD-1 signalling defines and protects leukaemic stem cells from T cell receptor-induced cell death in T cell acute lymphoblastic leukaemia.

Nature cell biology·2025
Same author

Author Correction: SHP-1 inhibition targets leukaemia stem cells to restore immunosurveillance and enhance chemosensitivity by metabolic reprogramming.

Nature cell biology·2025
Same author

Versatile platelets contribute to rejuvenation.

Life medicine·2025
Same author

Rapid and scalable personalized ASO screening in patient-derived organoids.

Nature·2025
Same author

SHP-1 inhibition targets leukaemia stem cells to restore immunosurveillance and enhance chemosensitivity by metabolic reprogramming.

Nature cell biology·2024

Related Experiment Video

Updated: Jul 5, 2025

Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging
10:03

Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging

Published on: August 1, 2017

11.7K

Immune System Influence on Hematopoietic Stem Cells and Leukemia Development.

John M Perry1,2,3

  • 1Children's Mercy Kansas City, Kansas City, MO, USA. jmperry@cmh.edu.

Advances in Experimental Medicine and Biology
|January 16, 2024
PubMed
Summary

Hematopoietic stem cells (HSCs) interact dynamically with the immune system, influencing cancer development and therapy. Understanding this immune microenvironment is key for future cancer treatments, especially for leukemic stem cells.

Keywords:
Hematopoietic stem cellImmune microenvironmentLeukemiaLeukemic stem cell

More Related Videos

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.2K
Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

9.1K

Related Experiment Videos

Last Updated: Jul 5, 2025

Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging
10:03

Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging

Published on: August 1, 2017

11.7K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.2K
Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

9.1K

Area of Science:

  • Immunology
  • Stem Cell Biology
  • Cancer Research

Background:

  • Hematopoietic stem cells (HSCs) generate all blood and immune cells.
  • HSCs reside within a specialized immune microenvironment.
  • Immune interactions with stem cells are crucial for health and disease.

Purpose of the Study:

  • To explore the nature of stem cells, particularly HSCs, within their immune microenvironment.
  • To investigate the implications of stem cell-immune interactions for current and future therapies.
  • To discuss the therapeutic potential of targeting immune-privileged states in leukemic stem cells (LSCs).

Main Methods:

  • Review of existing literature on stem cell-immune interactions.
  • Analysis of the concept of immune privilege in HSCs.
  • Exploration of cancer immunotherapy advancements and their relation to stem cells.

Main Results:

  • Stem cell-immune interactions are dynamic and change during stress and injury.
  • Cancer cells are not always immunotolerant; immunosurveillance eliminates pre-cancerous cells.
  • Stem cells play a critical role in cancer initiation, persistence, and therapy resistance.

Conclusions:

  • Understanding the immune microenvironment of stem cells is vital for developing novel cancer therapies.
  • Leukemic stem cells may inherit an immune-privileged state from HSCs, impacting treatment.
  • Stem cells represent a critical nexus in cancer prevention versus development through immune system interplay.